Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia.

Authors :: Ryland GL
Barraclough A
Fong CY
Fleming S
Bajel A
Hofmann O
Westerman D
Grimmond S
Blombery P
Source :: British journal of haematology [Br J Haematol] 2020 Oct; Vol. 191 (1), pp. 123-126. Date of Electronic Publication: 2020 Jul 09.
Publication Year :: 2020

Subjects :: Adolescent
Humans
Male
Drug Resistance genetics
Inotuzumab Ozogamicin administration & dosage
Mutation
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma genetics
Sialic Acid Binding Ig-like Lectin 2 genetics

Full Text Access

Tools